{"transactions":[{"id":854618,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"2026 Non-statutory Stock Option NQ","published_at":"2026-03-09T22:06:02.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":177500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 3, 2026. All other information remains unchanged from the March 3, 2026 filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":177500,"derivative":{"exercise_price":10.11,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":177500},"source":{"system":"sec-edgar","filing":"0001104659-26-025361","document":"tm268290-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025361/tm268290-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":859554,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T11:02:23.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":false,"shares":56334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date."}],"balance_after":112666,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":56334},"source":{"system":"sec-edgar","filing":"0001104659-26-023720","document":"tm268076-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023720/tm268076-2_4seq1.xml","form_type":"4"}},{"id":859553,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-03-05T11:02:23.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":22429,"price":9.49,"value":212851.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":134642,"source":{"system":"sec-edgar","filing":"0001104659-26-023720","document":"tm268076-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023720/tm268076-2_4seq1.xml","form_type":"4"}},{"id":859552,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-03-05T11:02:23.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":56334,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":157071,"source":{"system":"sec-edgar","filing":"0001104659-26-023720","document":"tm268076-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023720/tm268076-2_4seq1.xml","form_type":"4"}},{"id":870556,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"2026 Non-statutory Stock Option NQ","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":177500,"price":9.09,"value":1613475.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":177500,"derivative":{"exercise_price":9.09,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":177500},"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870555,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date."}],"balance_after":118000,"derivative":{"exercise_price":0,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870554,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 1, 2024, in each case subject to continued employment through such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":0,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870553,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the \"Plan\") vest on each of the first three (3) anniversaries of March 1, 2023, in each case subject to continued employment through such vesting date."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870552,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10969,"price":10.14,"value":111225.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":100737,"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870551,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111706,"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870550,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5375,"price":10.14,"value":54502.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":71706,"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":870549,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2026-03-04T02:34:10.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":77081,"source":{"system":"sec-edgar","filing":"0001104659-26-023070","document":"tm267953-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023070/tm267953-2_4seq1.xml","form_type":"4"}},{"id":1224132,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"2025 Restricted Stock Units RSU","published_at":"2025-03-05T22:02:21.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":169000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":169000,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":169000},"source":{"system":"sec-edgar","filing":"0001593968-25-000303","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000303/primary_01.xml","form_type":"4"}},{"id":1224131,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"2025 Non-statutory Stock Option NQ","published_at":"2025-03-05T22:02:21.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":253500,"price":7.87,"value":1995045.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":253500,"derivative":{"exercise_price":7.87,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":253500},"source":{"system":"sec-edgar","filing":"0001593968-25-000303","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000303/primary_01.xml","form_type":"4"}},{"id":1231747,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:39:00.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":0,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001593968-25-000285","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000285/primary_01.xml","form_type":"4"}},{"id":1231746,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:39:00.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":19600,"derivative":{"exercise_price":0,"expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001593968-25-000285","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000285/primary_01.xml","form_type":"4"}},{"id":1231745,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-03-04T23:39:00.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":10969,"price":8.33,"value":91371.77,"ownership":{"direct":true},"balance_after":57481,"source":{"system":"sec-edgar","filing":"0001593968-25-000285","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000285/primary_01.xml","form_type":"4"}},{"id":1231744,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-03-04T23:39:00.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5375,"price":8.33,"value":44773.75,"ownership":{"direct":true},"balance_after":68450,"source":{"system":"sec-edgar","filing":"0001593968-25-000285","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000285/primary_01.xml","form_type":"4"}},{"id":1231743,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-03-04T23:39:00.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":73825,"source":{"system":"sec-edgar","filing":"0001593968-25-000285","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000285/primary_01.xml","form_type":"4"}},{"id":1231742,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"officer":true,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2025-03-04T23:39:00.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":33825,"source":{"system":"sec-edgar","filing":"0001593968-25-000285","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000285/primary_01.xml","form_type":"4"}},{"id":1561111,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-26T23:02:19.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the March 1, 2024 grant date, in each case subject to continued employment through such vesting date."}],"balance_after":120000,"derivative":{"underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001104659-24-039166","document":"tm249879-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924039166/tm249879-5_4seq1.xml","form_type":"4"}},{"id":1599140,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-06T00:30:14.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":39200,"derivative":{"underlying":"Common Stock","underlying_shares":19600},"source":{"system":"sec-edgar","filing":"0001104659-24-031167","document":"tm248061-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924031167/tm248061-1_4seq1.xml","form_type":"4"}},{"id":1599139,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2024-03-06T00:30:14.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":5375,"price":5.39,"value":28971.25,"ownership":{"direct":true},"balance_after":14225,"source":{"system":"sec-edgar","filing":"0001104659-24-031167","document":"tm248061-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924031167/tm248061-1_4seq1.xml","form_type":"4"}},{"id":1599138,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Common Stock","published_at":"2024-03-06T00:30:14.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":19600,"price":5.39,"value":105644.0,"ownership":{"direct":true},"balance_after":19600,"source":{"system":"sec-edgar","filing":"0001104659-24-031167","document":"tm248061-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465924031167/tm248061-1_4seq1.xml","form_type":"4"}},{"id":1975914,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T22:02:08.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":58800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs subject to this grant under the Plan will vest with respect to one-third (1/3) of the RSUs on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date."}],"balance_after":58800,"derivative":{"underlying":"Common Stock","underlying_shares":58800},"source":{"system":"sec-edgar","filing":"0001209191-23-015688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123015688/doc4.xml","form_type":"4"}},{"id":1975913,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62127,"kind":"person","name":"O'Hara Elaine","position":1,"cik":"0001968045","reported_name":"O'Hara Elaine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Strategy Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-03T22:02:08.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":67900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the \"Company\") 2023 Inducement Plan (the \"Plan\") will vest on the first anniversary of the March 1, 2023 grant date (the \"Grant Date\"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date."}],"balance_after":67900,"derivative":{"exercise_price":6.86,"exercise_date":"2024-03-01","expiration_date":"2033-03-01","underlying":"Common Stock","underlying_shares":67900},"source":{"system":"sec-edgar","filing":"0001209191-23-015688","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000120919123015688/doc4.xml","form_type":"4"}}]}